Axalta (AXTA)
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
$35.78-0.53%
Close 2026-09-04 · 1-day change
NYSEMaterialsChemicals - SpecialtySnapshot 2026-09-04
Intact: The reason to own it still holds.
Axalta is growing steadily with analysts expecting about 4% revenue growth. Cash from operations improved strongly to $68M in Q1 2026 from $26M a year ago. The company is managing capital well, targeting CAPEX between $180M and $200M in 2026. The merger with Akzo Nobel could add growth potential.
The merger with Akzo Nobel poses risks that could hurt growth. Revenue growth is modest and below high-growth peers. The sector faces headwinds, and profit margins could come under pressure.
The stock trades about 21% below our fair value near $44, reflecting moderate growth expectations of 4% revenue increase. Our fair value is well above the Street median, indicating upside if execution improves.
Breaks if: Merger process stalls or is cancelled
Breaks if: CAPEX exceeds $210 million or falls below $170 million in FY26
cash from operations falls below $50 million per quarter
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable compounder with a focus on growth through merger activity. The current thesis is intact, as recent performance has been solid and management is executing on key priorities.
The market appears to have priced in a neutral outlook for AXTA, with a valuation that is cheap compared to peers. There is a slight expectations gap, indicating that the market does not anticipate significant changes in performance in the near term.
Fundamentals are likely to show steady progress as management continues to focus on completing the merger with Akzo Nobel and maintaining disciplined capital expenditures. Free cash flow is on an upward trajectory, but full-year results will be critical to assess overall performance.
The thesis hinges on maintaining guidance during upcoming calls, the performance of sector bellwethers, and potential inflationary pressures that could benefit the materials sector. Any cuts to guidance could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: YoY revenue growth falls below 3% next year
Overall, AXTA is positioned well for the next few years, but it faces risks that could affect its trajectory. Not investment advice.